THE JAK INHIBITOR (BARICITINIB) INHIBITS IFNΓ-INDUCED GLIOSTATIN EXPRESSION IN HUMAN FIBROBLAST-LIKE SYNOVIOCYTES

被引:1
|
作者
Joyo, Yuji [1 ]
Waguri-Nagaya, Yuko [2 ]
Kawaguchi, Yohei [1 ,3 ]
Oguri, Yusuke [1 ]
Nozaki, Masahiro [1 ]
Asai, Kiyofumi [3 ]
机构
[1] Nagoya City Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Nagoya, Aichi, Japan
[2] Nagoya City Univ, Grad Sch Med Sci, Dept Joint Surg Rheumat Dis, Nagoya, Aichi, Japan
[3] Nagoya City Univ, Grad Sch Med Sci, Dept Mol Neurobiol, Nagoya, Aichi, Japan
基金
日本学术振兴会;
关键词
D O I
10.1136/annrheumdis-2019-eular.4617
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AB0066
引用
收藏
页码:1497 / 1497
页数:1
相关论文
共 50 条
  • [1] THE JAK INHIBITOR (TOFACITINIB) INHIBITS TNF-INDUCED GLIOSTATIN/THYMIDINE PHOSPHORYLASE EXPRESSION IN HUMAN FIBROBLAST-LIKE SYNOVIOCYTES
    Kawaguchi, Y.
    Waguri-Nagaya, Y.
    Ikuta, K.
    Tatematsu, N.
    Kobayashi, M.
    Goto, H.
    Nozaki, M.
    Asai, K.
    Otsuka, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 441 - 441
  • [2] The Janus kinase inhibitor tofacitinib inhibits TNF-α-induced gliostatin expression in rheumatoid fibroblast-like synoviocytes
    Kawaguchi, Yohei
    Waguri-Nagaya, Yuko
    Tatematsu, Naoe
    Oguri, Yusuke
    Kobayashi, Masaaki
    Nozaki, Masahiro
    Asai, Kiyofumi
    Aoyama, Mineyoshi
    Otsuka, Takanobu
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (04) : 559 - 567
  • [3] The Janus kinase inhibitor (baricitinib) suppresses the rheumatoid arthritis active marker gliostatin/thymidine phosphorylase in human fibroblast-like synoviocytes
    Joyo, Yuji
    Kawaguchi, Yohei
    Yonezu, Hiroki
    Senda, Hiroya
    Yasuma, Sanshiro
    Shiraga, Hiroo
    Nozaki, Masahiro
    Aoyama, Mineyoshi
    Asai, Kiyofumi
    Murakami, Hideki
    Waguri-Nagaya, Yuko
    IMMUNOLOGIC RESEARCH, 2022, 70 (02) : 208 - 215
  • [4] The Janus kinase inhibitor (baricitinib) suppresses the rheumatoid arthritis active marker gliostatin/thymidine phosphorylase in human fibroblast-like synoviocytes
    Yuji Joyo
    Yohei Kawaguchi
    Hiroki Yonezu
    Hiroya Senda
    Sanshiro Yasuma
    Hiroo Shiraga
    Masahiro Nozaki
    Mineyoshi Aoyama
    Kiyofumi Asai
    Hideki Murakami
    Yuko Waguri-Nagaya
    Immunologic Research, 2022, 70 : 208 - 215
  • [5] Mithramycin has inhibitory effects on gliostatin and matrix metalloproteinase expression induced by gliostatin in rheumatoid fibroblast-like synoviocytes
    Tatematsu, Naoe
    Waguri-Nagaya, Yuko
    Kawaguchi, Yohei
    Oguri, Yusuke
    Ikuta, Kenji
    Kobayashi, Masaaki
    Nozaki, Masahiro
    Asai, Kiyofumi
    Aoyama, Mineyoshi
    Otsuka, Takanobu
    MODERN RHEUMATOLOGY, 2018, 28 (03) : 495 - 505
  • [6] BARICITINIB ABROGATES IFNγ-INDUCED FOCAL ADHESION KINASE (FAK) ACTIVATION IN FIBROBLAST-LIKE SYNOVIOCYTES
    Karonitsch, T.
    Wunrau, C.
    Beckmann, D.
    Dalwigk, K.
    Byrne, R.
    Niederreiter, B.
    Wanivenhaus, A.
    Holinka, J.
    Scheinecker, C.
    Steiner, G.
    Smolen, J. S.
    Pap, T.
    Kiener, H. P.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : A57 - A57
  • [7] GLIOSTATIN REGULATES VASCULAR ENDOTHELIAL GROWTH-FACTOR PRODUCTION IN HUMAN FIBROBLAST-LIKE SYNOVIOCYTES
    Kawaguchi, Y.
    Waguri-Nagaya, Y.
    Tatematsu, N.
    Kobayashi, M.
    Goto, H.
    Nozaki, M.
    Ikuta, K.
    Aoyama, M.
    Asai, K.
    Otsuka, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 373 - 374
  • [8] IFNγ promotes fibroblast-like synoviocytes motility
    Karonitsch, T.
    Dalwigk, K.
    Byrne, R.
    Niedereiter, B.
    Cetin, E.
    Wanivenhaus, A.
    Scheinecker, C.
    Smolen, J. S.
    Kiener, H. P.
    CYTOKINE, 2009, 48 (1-2) : 96 - 96
  • [9] IFNγ PROMOTES THE INVASIVE BEHAVIOR OF FIBROBLAST-LIKE SYNOVIOCYTES
    Karonitsch, T.
    Dalwigk, K.
    Wunrau, C.
    Byrne, R.
    Niedereiter, B.
    Hofstaetter, J.
    Wanivenhaus, A.
    Scheinecker, C.
    Pap, T.
    Smolen, J. S.
    Kiener, H. P.
    ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 : A48 - A48
  • [10] Paeonol inhibits TNF-α-induced GM-CSF expression in fibroblast-like synoviocytes
    Li, Yan
    Li, Pin
    Lin, Shu-huan
    Zheng, Yi-qing
    Zheng, Xiang-xiong
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2014, 52 (11) : 986 - 995